Galileo Resources plc (GLR) announced that on 15 June 2026 it entered into a conditional share purchase agreement with Metal Capital Exploration Limited, a wholly owned subsidiary of ASX-listed Sandfire Resources Limited, with Sandfire acting as purchaser guarantor. “Metal Capital is a wholly owned subsidiary of Sandfire, with whom Galileo has an existing relationship in Botswana.
From Galileo’s point of view the transaction makes strategic sense as our highly prospective portfolio and our people resources are primarily located in Zambia and Zimbabwe, so we are better equipped to focus on and advance projects there. The structure of the transaction provides for consideration now and a significant future success payment if our belief in the potential of the Prospecting Licences is realised. We look forward to Metal Capital progressing the agreed Exploration Commitment and wish them every success in this regard.”
Comment: GLR remains one of the more unappreciated plays in the Colin Bird stable, something which is underlined in the wake of today’s announcement yet further. Ideally, the market will start to appreciate how prospective the GLR portfolio is from now.
Cizzle Biotechnology (CIZ), the UK based diagnostics developer of early cancer tests, announced the successful laboratory accreditation of its proprietary test for the CIZ1B biomarker which is highly associated with early-stage lung cancer. Working closely with the Company’s North American licensing partner Cizzle Bio Inc,, the test is now approved for use under Clinical Laboratory Improvement Amendments accreditation at OmniHealth Diagnostics, a CLIA-certified, COLA-accredited clinical laboratory based in Dallas, Texas.
Comment: We have already noted the breakout in the CIZ share price, which has highlighted the way that the company is also making a breakthrough fundamentally. This means that today’s announcement should be an ongoing type of news for the company, and for shareholders to enjoy. 3 year resistance at 4.5p beckons by the end of the summer.
Gana Media Group (GANA) the AIM quoted content and data intelligence company which aims to create a leading integrated sports, media and entertainment conglomerate focused within the Latin American region, and particularly the Mexican market, announced a Placing and Subscription by a number of investors including Directors to raise £750,000 before expenses as outlined below. The Company updated on Estadio Gana (www.estadiogana.mx), its licensed online casino and sportsbook in Mexico. Trading momentum has continued to build through the second quarter, with new registrations and wagering volumes (total betting) up significantly. The Board believes this growth supports the rationale for today’s fundraising and positions the brand well for the World Cup window and beyond. The Company intends to use the proceeds of the Fundraise to increase spending on a number of key projects that we believe will energise our growth further.
Comment: After all the excited and gung-ho announcements regarding deal making that did not mention any numbers, we have the placing, perhaps at a rather lower share price than the company would have liked. Using the money to spend on key projects sounds a little counterintuitive, if they are all growing anyway.
Pri0r1ty Intelligence Group PLC (PR1), the AI focused business delivering growth solutions to SMEs, announce that its Halfspace Limited business has entered into a partnership agreement with the Sport & Recreation Alliance as its official AI partner. Halfspace will offer data solutions and AI tools to nearly 300 member organisations across the sports and recreation sector with an estimated 15,000 users through SportTower.ai, the Company’s new platform for the sports and recreation sector.
Comment: We might have thought that following the Halfspace deal, PR1 would finally be on its way. Instead, Halfspace is still trying to find its way and make a land grab. The worry here is that the chosen market of SMEs is both skint (blame Rachel Reeves) and does not understand the Halfspace offering (they are old).
Inspiration Healthcare Group plc (IHC), the global medical technology company, pioneering, specialist neonatal intensive care medical devices, announces its final results for the year ended 31 January 2026. Group revenue of £47.5m (FY25: £38.3m) up 24% on prior year. Gross profit of £20.8m (up 27% year-on-year) with margin of 43.7% (FY25: 42.8%). Adjusted EBITDA of £2.8m (FY25: £0.2m). IHC said FY26 has been a transformational year for the Group. The period has marked a transition from stabilisation under our Back-to-Basics strategy to growth execution, with a core focus on global market expansion, product innovation especially with regard to consumables and services; and operational efficiency improvements across the Group. We are positioned to scale through our three core platforms and strengthen our global leadership in neonatal ventilation and related neonatal medtech solutions.
Comment: Not only a transition, but a transformation, something which sees IHC finally living up to its name as far as being a turnaround story. The magic word in the RNS is “scale” with the big question being whether the company can successfully do this internationally.
MediaZest plc (MDZ), the creative audio-visual solutions provider, reports its unaudited interim results for the six months ended 31 March 2026, showing considerable improvement on the prior comparative period. The Group has delivered significant revenue growth, profitability at the EBITDA level and a substantial profit before tax. This positive trend is expected to continue in the second half of the financial year with ongoing projects continuing to roll out, and MediaZest expects to report year-on-year growth again for the full year following strong growth in the prior year. EBITDA is lower than the H1 FY25 comparative, despite the increase in revenues in the first half of the year. This reflects increased costs, a proportion of which is one-off costs relating to investments in the engineering team and systems to meet the increased demand and ongoing support of new sites.
Comment: I was wondering whether to include MDZ in today’s list given that it really is a microcap and still only has a market cap of £2m. Indeed, the shares are up three years in a row, something which underlines the way that the company is punching above its weight in terms of visibility.
Active Energy Group plc (AEG) announced that it has signed a strategic distribution agreement with Fog Hashing Pte. Ltd., a leading provider of modular digital infrastructure solutions for high-performance computing, artificial intelligence and digital asset hosting applications. The Agreement provides Active Energy with distribution rights across the Gulf Cooperation Council region and establishes a framework under which the parties may explore a broader exclusive relationship, subject to the achievement of agreed commercial milestones and the execution of further definitive agreements. The Board believes the Agreement represents a significant milestone in the continued development of Active Energy’s digital infrastructure platform across the UAE and wider GCC region, utilising ultra low-cost power.
Comment: AEG is clearly continuing to consolidate its grip on the Gulf region, something which in the wake of the “peace” deal this week, looks to be a wise move. Just as important is the way that the company is rubbing shoulders with key, blue chip players, underlining the momentum it is building.
Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that it has received formal notification of the decision to grant for its POLB 001 cancer immunotherapy-induced Cytokine Release Syndrome patent application from the European Patent Office. This represents a significant milestone for the Company’s global intellectual property strategy. The European patent, which provides protection across EPO member states, is the most commercially significant grant to date within Poolbeg’s cancer immunotherapy-induced CRS patent family, covering one of the world’s largest and most important pharmaceutical markets.
Comment: A little birdy told me recently that POLB is one to watch, and in quite a seriously positively way, and this has been underlined with the newsflow in recent weeks, as well as the share price strength. It really does look as though the company’s time has finally come.
boohoo group plc (DEBS) Debenhams Group Adjusted EBITDA £53.3m up 35% year-on-year. Debenhams Brand GMV £730m (+11.6%), Adjusted EBITDA £34.8m (+38.5%). DEBS said “This has been a year of significant and successful transformation for Debenhams Group. Since my appointment as Group Chief Executive in November 2024, I have been sharply focused on executing our multi-year turnaround strategy – and the progress is clear. We delivered £53.3m of Adjusted EBITDA, up 35% year-on-year following two trading upgrades and turned every brand profitable on the same basis.”
Comment: I wish that DEBS would sort out its ticker code to something appropriate like BOO. Nevertheless, the company’s CEO is fully within his rights to boast about the achievements made since he put his feet under the desk at the end of 2024. The question now is far high the shares can now fly towards 30p?
CleanTech Lithium PLC (CTL), an exploration and development company advancing sustainable lithium projects in Chile, announced that Steve Kesler, Non-Executive Chairman, has subscribed for 4,604,550 new Ordinary Shares in the Company at a price of 6 pence per share. Steve Kesler confirmed his intention to subscribe for the Subscription Shares to settle accrued director’s fees owed to him by the Company. Following the announcement of the Company’s financial results for the year ended 31 December 2025, the Company is no longer in a closed period, and Steve Kesler is now permitted to subscribe for the Subscription Shares.
Comment: With shares of CTL at bargain basement levels, especially in market cap terms, in the wake of the recent fundraise, it is not surprising that the Chairman is leading from the front in terms of buying a decent chunk of stock at the lower levels. 5p -6p has been the floor for the stock in recent years.
TAM (TAM), the investment management and IFA support services group, today announces its audited final results for the year ended 31 March 2026, which show strong, double-digit organic growth across revenue, adjusted operating profit2 and adjusted earnings per share4, which are all ahead of market expectations, driven by strong growth in AUM/I1 and underlying3 net inflows. Group revenue increased by 20.1% to £54.436m (FY25: £45.309m). Adjusted operating profit2 up 24.1% to £28.485m (FY25: £22.946m).Adjusted operating profit margin increased to 52.3% (FY25: 50.6%) .
Comment: A blow the lights out update from TAM, and from a company which is clearly moving up from being a small cap of interest to a fully fledged growth situation. This is particularly highlighted by the way that we have strong margins, and an all round winnning performance. All that is left now is for the share price to catch up with the glory.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
